Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Eisai Co Ltd

Recent news which mentions Eisai Co Ltd

Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags U/S/ Economy Business News US: News
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Politics Policy Epidemics
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Coronavirus Quest Diagnostics Inc Biogen Inc
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Eisai Co Ltd Biotech and Pharmaceuticals Business
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Health & Science Biogen Inc Health care industry
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Breaking News: Business Science Companies
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Biotechnology US: News Biotech and Pharmaceuticals
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Business Biotech and Pharmaceuticals US Economy
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Breaking News: Business Politics Policy
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Pandemics Business Biotech and Pharmaceuticals
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags Eisai Co Ltd US Economy Business
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags Pandemics US Economy Eisai Co Ltd
From CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
Tags Health care industry Biogen Inc Coronavirus
From CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
Tags Halliburton Co Economy Toro Co
From CNBC.com News
Stocks making the biggest moves premarket: Biogen, Thor Industries, Lyft and more
Tags Market Insider Ocugen Inc Biogen Inc
From CNBC.com News
Why Biogen's Alzheimer's drug Aduhelm is so controversial
Tags Health & Science Pharmaceuticals Medicare
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.